Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Phase Genomics Inc. is a biotechnology company revolutionizing genomics research through its proprietary Hi-C and proximity ligation technologies. They develop and commercialize kits, reagents, software, and services that enable researchers to obtain chromosome-scale genome assemblies, deconvolute complex metagenomes, and discover novel genomic interactions. Their solutions are applied across diverse fields including agriculture, infectious disease, conservation biology, and human health, empowering scientists to unlock deeper insights into the organization and function of genomes.
Core research and development, product manufacturing, global operations management, and administrative functions.
State-of-the-art laboratory facilities for genomics research, sequencing, and bioinformatics, situated in Seattle's biotech hub.
A dynamic, innovative, and collaborative environment driven by scientific curiosity and a passion for advancing genomics. Employees often have backgrounds in molecular biology, bioinformatics, and software engineering.
The Seattle HQ serves as the nerve center for Phase Genomics' pioneering work in proximity ligation technology, driving innovation and product development that impacts global genomic research.
While headquartered in Seattle, Phase Genomics Inc. supports a global customer base through direct sales, international distributors, and online platforms. Their products and services are utilized by academic institutions, research organizations, and commercial entities worldwide, facilitating genomic research across numerous countries. They offer global technical support and collaborate with international researchers.
1617 8th Ave N, Suite 300
Seattle
WA
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Phase Genomics Inc.' leadership includes:
Phase Genomics Inc. has been backed by several prominent investors over the years, including:
Based on publicly available information, Phase Genomics Inc. has maintained a stable core executive team over the past 12 months with no major publicized hires or departures at the C-suite level. This suggests continuity in leadership and strategic direction.
Discover the tools Phase Genomics Inc. uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Phase Genomics Inc. primarily uses the email format combining the first initial and last name, or the full first name, followed by '@phasegenomics.com'.
[first_initial][last]@phasegenomics.com or [first].[last]@phasegenomics.com
Format
iliachko@phasegenomics.com
Example
90%
Success rate
Business Wire • October 17, 2023
Phase Genomics today announced the launch of its OncoTerra™ platform, a new proximity ligation (Hi-C) based solution designed to enhance cytogenomics research in cancer. The platform offers unprecedented resolution and insights into complex structural variations and genome architecture characteristic of cancer cells....more
GenomeWeb • August 2, 2023
Phase Genomics has been awarded a $1.8 million Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) to further develop its proximity ligation technology for metagenomics. The funding will support the creation of tools to improve the assembly and analysis of genomes from complex microbial communities....more
PR Newswire • May 4, 2023
Phase Genomics introduced a new proximity ligation assay, enabling ultra-long-range genomic analysis. This advancement is set to provide researchers with enhanced capabilities for mapping complex genomes and identifying large-scale structural variations....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Phase Genomics Inc., are just a search away.